Efficacy of botulinum toxin and surgery in managing acute acquired comitant esotropia
The success rate after BTX injection was similar to that of surgery for 3 months but lower at 6 months post-treatment. Patients who received BTX showed restoration of stereopsis within the initial first postoperative month, with sustained preservation of this function across 6 months post-treatment. Anisometropia of 1 D may indicate suitability for BTX injection as a preferred treatment option for AACE. Trial registration This study was registered on the Chinese Clinical Trial Registry (ChiCTR2100053717. Registered 28 November 2021. https://www.chictr.org.cn/showprojEN.html?proj=140975 ).
Authors
- Jiayu Chen (ORCID: https://orcid.org/0000-0002-3710-0000)
- Jing Fu (ORCID: https://orcid.org/0000-0002-2939-9479)
- Weibin Chen (ORCID: https://orcid.org/0000-0002-1689-7583)
- Huijian Li
- Jie Hao
- Zhaojun Meng (ORCID: https://orcid.org/0000-0003-2916-5004)
- Xiangxiang Liu (ORCID: https://orcid.org/0000-0002-4934-6227)
Institutions
- Beijing Tongren Hospital (CN)
Publication Details
- Journal
- Eye and Vision
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1186/s40662-025-00431-7
- Citations
- 1
- Primary Topic
- Ophthalmology and Eye Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- National Natural Science Foundation of China
- National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
- Capital Health Research and Development of Special Fund